CoaguChek XS in Antiphospholipid Antibody Syndrome (APL) Patients

Completed

Conditions studied: Antiphospholipid Antibody Syndrome

In brief

The purpose of this study is to see if the CoaguChek XS is accurate in measuring International Normalized Ratio (INR) in patients with Antiphospholipid Antibody Syndrome (APL) receiving warfarin therapy.

Key facts

Study ID

NCT02139072

Run by

University of Florida

People needed

60

Starts

2015-03-01

Expected to finish

2016-01-01

Last updated by the study team

2016-10-04

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18-65 years of age
• anticoagulated with warfarin for at least 1 month
• Diagnosis of antiphospholipid antibody syndrome for intervention arm

You may not qualify if…

• any type of mental disability that would hinder their ability to give informed consent
• any terminal illness or any other condition that could interfere with study completion, that person will be excluded.

Where it is running

• UF and Shands Health — Gainesville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.